Australia
Argentina 
Austria 
Brazil 
Canada 
Germany 
Ireland 
Italy 
Malaysia 
Mexico 
New Zealand 
Poland 
South Africa 
United Kingdom 
United States Nasdaq
Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement
Applied DNA Sciences, Inc. (NASDAQ:APDN), a leader in PCR-based DNA technologies, has successfully met the Nasdaq minimum bid price requirement. This achievement demonstrates the company's commitment to maintaining compliance with Nasdaq's standards and regulations.
Investors and stakeholders can now have increased confidence in Applied DNA's financial stability and market position. This development marks an important milestone for the company and reflects its dedication to upholding the highest standards of corporate governance.
